Rubella: Clinical Trials

3 trials for Rubella, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Unknown 3

Follow Rubella: new trials by email Literature Review of Rubella trials Research Report on Rubella

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines
Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine, Inactivated SARS-CoV-2 vaccine coadministered with MMR, Inactivated SARS-CoV-2 vaccine administered alone - SARS-CoV-2 Infection, Varicella
Phase 4UnknownShanghai Municipal Center for Disease Control and Prevention5402023-08-012023-07-19
The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine
HPV+MMR(0d),HPV(6m), HPV(0d),HPV(6m),MMR(7m), MMR(0d),HPV(1m),HPV(7m) - Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18
Phase 4UnknownZhejiang Provincial Center for Disease Control and Prevention3002021-08-252022-03-29
Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients
MMR vaccination - Measles
Phase 4UnknownKlara M. Pósfay Barbe902013-04-012020-09-18

Narrower conditions

Measles (3)  ·  Mumps (3)  ·  COVID-19 (1)  ·  Chickenpox (1)  ·  Escherichia coli Infections (1)

Broader conditions

Infections (3)  ·  Mononegavirales Infections (3)  ·  Morbillivirus Infections (3)  ·  Mouth Diseases (3)  ·  Paramyxoviridae Infections (3)  ·  Parotid Diseases (3)  ·  Parotitis (3)  ·  RNA Virus Infections (3)  ·  Rubivirus Infections (3)  ·  Rubulavirus Infections (3)  ·  Salivary Gland Diseases (3)  ·  Stomatognathic Diseases (3)  ·  Togaviridae Infections (3)  ·  Virus Diseases (3)  ·  Bacterial Infections (1)

Sponsors

Klara M. Pósfay Barbe (1)  ·  Shanghai Municipal Center for Disease Control and Prevention (1)  ·  Zhejiang Provincial Center for Disease Control and Prevention (1)

Countries

China (2)  ·  Switzerland (1)

Top investigators

Klara M Posfay-Barbe, MD, MS (1)  ·  Zhuoying Huang (1)

Results publications

PMID 41276263